Thanks to the latest ELLA system, we are joining the fight against the COVID-19 virus for the Immuno-monitoring of patients. In partnership with the virology department, the PPC participates in the evaluation of the worsening clinical condition of patients in order to improve their management. Indeed, in the follow-up of high-risk patients infected with COVID19 , it appears that the measurement of IL-1beta, IL-6, TNF-alpha and IL-8 is crucial for understanding the evolution of the disease and adapting treatments. This panel was set up by Bio-Techne in collaboration with, and at the request of :

– Mount Sinai hospital (New York) (see link here)

– Spallanzani hospital (Rome)

– National institute of infectious diseases (Rome)

– the delegation of clinicians from Wuhan in China advising Italian health agencies